Literature DB >> 21199105

Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease.

Rafael Sivera1, Carmen Espinós, Juan J Vílchez, Fernando Mas, Dolores Martínez-Rubio, María José Chumillas, Fernando Mayordomo, Nuria Muelas, Luis Bataller, Francesc Palau, Teresa Sevilla.   

Abstract

Mutations in the ganglioside-induced-differentiation-associated protein 1 gene (GDAP1) can cause Charcot-Marie-Tooth (CMT) disease with demyelinating (CMT4A) or axonal forms (CMT2K and ARCMT2K). Most of these mutations present a recessive inheritance, but few autosomal dominant GDAP1 mutations have also been reported. We performed a GDAP1 gene screening in a clinically well-characterized series of 81 index cases with axonal CMT neuropathy, identifying 17 patients belonging to 4 unrelated families in whom the heterozygous p.R120W was found to be the only disease-causing mutation. The main objective was to fully characterize the neuropathy caused by this mutation. The clinical picture included a mild-moderate phenotype with onset around adolescence, but great variability. Consistently, ankle dorsiflexion and plantar flexion were impaired to a similar degree. Nerve conduction studies revealed an axonal neuropathy. Muscle magnetic resonance imaging studies demonstrated selective involvement of intrinsic foot muscles in all patients and a uniform pattern of fatty infiltration in the calf, with distal and superficial posterior predominance. Pathological abnormalities included depletion of myelinated fibers, regenerative clusters and features of axonal degeneration with mitochondrial aggregates. Our findings highlight the relevance of dominantly transmitted p.R120W GDAP1 gene mutations which can cause an axonal CMT with a wide clinical profile.
© 2010 Peripheral Nerve Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21199105     DOI: 10.1111/j.1529-8027.2010.00286.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  23 in total

1.  Charcot-Marie-Tooth disease: genetic and clinical spectrum in a Spanish clinical series.

Authors:  Rafael Sivera; Teresa Sevilla; Juan Jesús Vílchez; Dolores Martínez-Rubio; María José Chumillas; Juan Francisco Vázquez; Nuria Muelas; Luis Bataller; José María Millán; Fancesc Palau; Carmen Espinós
Journal:  Neurology       Date:  2013-09-27       Impact factor: 9.910

Review 2.  Mitochondrial dynamics in neuronal injury, development and plasticity.

Authors:  Kyle H Flippo; Stefan Strack
Journal:  J Cell Sci       Date:  2017-02-02       Impact factor: 5.285

Review 3.  A review of genetic counseling for Charcot Marie Tooth disease (CMT).

Authors:  Carly E Siskind; Seema Panchal; Corrine O Smith; Shawna M E Feely; Joline C Dalton; Alice B Schindler; Karen M Krajewski
Journal:  J Genet Couns       Date:  2013-04-21       Impact factor: 2.537

Review 4.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

5.  [Analysis of GDAP1 gene mutation in a pedigree with autosomal dominant Charcot-Marie-Tooth disease].

Authors:  Li Qin; Canhong Yang; Tianming Lü; Lanying Li; Dandan Zong; Yueying Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30

6.  WES homozygosity mapping in a recessive form of Charcot-Marie-Tooth neuropathy reveals intronic GDAP1 variant leading to a premature stop codon.

Authors:  Marion Masingue; Jimmy Perrot; Robert-Yves Carlier; Guenaelle Piguet-Lacroix; Philippe Latour; Tanya Stojkovic
Journal:  Neurogenetics       Date:  2018-02-02       Impact factor: 2.660

7.  Dominant GDAP1 founder mutation is a common cause of axonal Charcot-Marie-Tooth disease in Finland.

Authors:  Mari Auranen; Emil Ylikallio; Jussi Toppila; Mirja Somer; Sari Kiuru-Enari; Henna Tyynismaa
Journal:  Neurogenetics       Date:  2013-03-03       Impact factor: 2.660

Review 8.  Inherited peripheral neuropathies.

Authors:  Mario A Saporta; Michael E Shy
Journal:  Neurol Clin       Date:  2013-03-05       Impact factor: 3.806

9.  Variant pathogenicity evaluation in the community-driven Inherited Neuropathy Variant Browser.

Authors:  Cima Saghira; Dana M Bis; David Stanek; Alleene Strickland; David N Herrmann; Mary M Reilly; Steven S Scherer; Michael E Shy; Stephan Züchner
Journal:  Hum Mutat       Date:  2018-03-14       Impact factor: 4.878

10.  SNP array-based whole genome homozygosity mapping as the first step to a molecular diagnosis in patients with Charcot-Marie-Tooth disease.

Authors:  Carina Fischer; Slave Trajanoski; Lea Papić; Christian Windpassinger; Günther Bernert; Michael Freilinger; Maria Schabhüttl; Mine Arslan-Kirchner; Poupak Javaher-Haghighi; Barbara Plecko; Jan Senderek; Christian Rauscher; Wolfgang N Löscher; Thomas R Pieber; Andreas R Janecke; Michaela Auer-Grumbach
Journal:  J Neurol       Date:  2011-09-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.